Bank of New York Mellon’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $909K | Buy |
166,265
+189
| +0.1% | +$1.03K | ﹤0.01% | 3161 |
|
|
2025
Q1 | $1.04M | Buy |
166,076
+25,857
| +18% | +$163K | ﹤0.01% | 3028 |
|
|
2024
Q4 | $578K | Buy |
140,219
+2,935
| +2% | +$12.1K | ﹤0.01% | 3429 |
|
|
2024
Q3 | $459K | Sell |
137,284
-41,227
| -23% | -$138K | ﹤0.01% | 3560 |
|
|
2024
Q2 | $532K | Buy |
178,511
+49,884
| +39% | +$149K | ﹤0.01% | 3549 |
|
|
2024
Q1 | $444K | Sell |
128,627
-4,754
| -4% | -$16.4K | ﹤0.01% | 3597 |
|
|
2023
Q4 | $179K | Sell |
133,381
-699
| -0.5% | -$937 | ﹤0.01% | 3975 |
|
|
2023
Q3 | $292K | Buy |
134,080
+2,213
| +2% | +$4.82K | ﹤0.01% | 3801 |
|
|
2023
Q2 | $315K | Buy |
131,867
+117,769
| +835% | +$281K | ﹤0.01% | 3797 |
|
|
2023
Q1 | $26.1K | Hold |
14,098
| – | – | ﹤0.01% | 4275 |
|
|
2022
Q4 | $27.2K | Hold |
14,098
| – | – | ﹤0.01% | 4315 |
|
|
2022
Q3 | $22K | Buy |
+14,098
| New | +$22K | ﹤0.01% | 4442 |
|